COMING SOON: EARLY NSCLC

COMING SOON: EARLY NSCLC

UPCOMING Join us forour roundtable in||latest advances in||your questions on||new therapies for||practice changes in||your patient cases in EARLY NSCLC Jonathan Spicer McGill University Health Centre, Montreal, Canada Salma Jabbour Rutgers Cancer Institute of New...
Coming Soon: Antibody Drug Conjugates

Coming Soon: Antibody Drug Conjugates

UPCOMING Join us forour roundtable in||latest advances in||your questions on||new therapies for||practice changes in||your patient cases in Antibody Drug Conjugates Giuseppe Banna Portsmouth Hospitals NHS Trust, UK Alessandra Curioni Cantonal Hospital Fribourg,...
Lung Cancer (ASCO 2024)

Lung Cancer (ASCO 2024)

Lung Cancer (ASCO 2024) Welcome & introduction by host Alfredo Addeo WHAT’S NEW IN TARGETED THERAPIES FOR NSCLC? XIUNING LE LATEST INSIGHTS IN ADCS FOR LUNG CANCER LIZZA HENDRIKS NEW ADVANCES IN IMMUNOTHERAPIES FOR LUNG CANCER ALFREDO ADDEO  } 1 h 32 min Get Your CME...
HER2 in Lung, GYNE & GI Cancers

HER2 in Lung, GYNE & GI Cancers

HER2 in Lung, GYNE & GI Cancers Welcome & introduction by host Ilaria Colombo Clinical implications of HER2 in gastrointestinal cancers Florian Lordick Treatment considerations for HER2-positive lung cancer Maximilian Hochmair Latest treatment updates in...
Biomarkers in GI & Lung

Biomarkers in GI & Lung

Biomarkers in GI & Lung The Significance of Biomarkers in GI Oncology for My Therapy Decision Sara De Dosso Biomarkers in GI Oncology: The Tests We Perform in Gastric and GEJ Today Rupert Langer Current Standards in in Lung Cancer Therapy: Which Biomarkers We...